Template:Paraganglioma: Difference between revisions

	Paraganglioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Paraganglioma from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Paraganglioma On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Paraganglioma All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Paraganglioma
CDC on Paraganglioma
Paraganglioma in the news
Blogs on Paraganglioma
Directions to Hospitals Treating Paraganglioma
Risk calculators and risk factors for Paraganglioma

@@ Line 59: / Line 59: @@
 !
 [[Paraganglioma epidemiology and demographics|Epidemiology and Demographics]]
-|-
-!
-|- bgcolor="Pink"
-!
-[[Paraganglioma risk factors|Risk Factors]]
-|-
-!
-|- bgcolor="Pink"
-!
-[[Paraganglioma screening|Screening]]
 |-
 !
@@ Line 101: / Line 89: @@
 !
 [[Paraganglioma physical examination|Physical Examination]]
-|-
-!
-|- bgcolor="LightSkyBlue"
-!
-[[Paraganglioma laboratory findings|Laboratory Findings]]
-|-
-!
-|- bgcolor="LightSkyBlue"
-!
-[[Paraganglioma electrocardiogram|Electrocardiogram]]
 |-
 !
@@ Line 131: / Line 107: @@
 !
 [[Paraganglioma MRI|MRI]]
-|-
-!
-|- bgcolor="LightSkyBlue"
-!
-[[Paraganglioma echocardiography or ultrasound|Echocardiography or Ultrasound]]
 |-
 !
@@ Line 169: / Line 139: @@
 |-
 !
-|- bgcolor="PaleTurquoise"
-!
-[[Paraganglioma primary prevention|Primary Prevention]]
-|-
-!
-|- bgcolor="PaleTurquoise"
-!
-[[Paraganglioma secondary prevention|Secondary Prevention]]
-|-
-!
 |- bgcolor="PaleTurquoise"

Revision as of 13:56, 11 September 2012